1.1CLJan 5
Toward Global Large Language Models in MedicineRui Yang, Huitao Li, Weihao Xuan et al.
Despite continuous advances in medical technology, the global distribution of health care resources remains uneven. The development of large language models (LLMs) has transformed the landscape of medicine and holds promise for improving health care quality and expanding access to medical information globally. However, existing LLMs are primarily trained on high-resource languages, limiting their applicability in global medical scenarios. To address this gap, we constructed GlobMed, a large multilingual medical dataset, containing over 500,000 entries spanning 12 languages, including four low-resource languages. Building on this, we established GlobMed-Bench, which systematically assesses 56 state-of-the-art proprietary and open-weight LLMs across multiple multilingual medical tasks, revealing significant performance disparities across languages, particularly for low-resource languages. Additionally, we introduced GlobMed-LLMs, a suite of multilingual medical LLMs trained on GlobMed, with parameters ranging from 1.7B to 8B. GlobMed-LLMs achieved an average performance improvement of over 40% relative to baseline models, with a more than threefold increase in performance on low-resource languages. Together, these resources provide an important foundation for advancing the equitable development and application of LLMs globally, enabling broader language communities to benefit from technological advances.
4.2CLJan 29, 2024
Development and Testing of a Novel Large Language Model-Based Clinical Decision Support Systems for Medication Safety in 12 Clinical SpecialtiesJasmine Chiat Ling Ong, Liyuan Jin, Kabilan Elangovan et al.
Importance: We introduce a novel Retrieval Augmented Generation (RAG)-Large Language Model (LLM) framework as a Clinical Decision Support Systems (CDSS) to support safe medication prescription. Objective: To evaluate the efficacy of LLM-based CDSS in correctly identifying medication errors in different patient case vignettes from diverse medical and surgical sub-disciplines, against a human expert panel derived ground truth. We compared performance for under 2 different CDSS practical healthcare integration modalities: LLM-based CDSS alone (fully autonomous mode) vs junior pharmacist + LLM-based CDSS (co-pilot, assistive mode). Design, Setting, and Participants: Utilizing a RAG model with state-of-the-art medically-related LLMs (GPT-4, Gemini Pro 1.0 and Med-PaLM 2), this study used 61 prescribing error scenarios embedded into 23 complex clinical vignettes across 12 different medical and surgical specialties. A multidisciplinary expert panel assessed these cases for Drug-Related Problems (DRPs) using the PCNE classification and graded severity / potential for harm using revised NCC MERP medication error index. We compared. Results RAG-LLM performed better compared to LLM alone. When employed in a co-pilot mode, accuracy, recall, and F1 scores were optimized, indicating effectiveness in identifying moderate to severe DRPs. The accuracy of DRP detection with RAG-LLM improved in several categories but at the expense of lower precision. Conclusions This study established that a RAG-LLM based CDSS significantly boosts the accuracy of medication error identification when used alongside junior pharmacists (co-pilot), with notable improvements in detecting severe DRPs. This study also illuminates the comparative performance of current state-of-the-art LLMs in RAG-based CDSS systems.